FDA Appoves Generic Metrogel

Israeli generic drug maker Taro Pharmaceutical Industries Ltd. on Tuesday said it received clearance from the Food and Drug Administration for its New Drug Application for metronidazole topical gel USP, 0.75 percent, or metronidazole gel.
The company said its metronidazole gel is a prescription product used to treat rosacea. The company said it is the bioequivalent to MetroGel Topical Gel, 0.75 percent, made by Galderma Laboratories LP.